These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11465422)

  • 1. SEM imaging predicts quality of niosomes from maltodextrin-based proniosomes.
    Blazek-Welsh AI; Rhodes DG
    Pharm Res; 2001 May; 18(5):656-61. PubMed ID: 11465422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maltodextrin-based proniosomes.
    Blazek-Welsh AI; Rhodes DG
    AAPS PharmSci; 2001; 3(1):E1. PubMed ID: 11741252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ niosome forming maltodextrin proniosomes of candesartan cilexetil: In vitro and in vivo evaluations.
    Yuksel N; Bayindir ZS; Aksakal E; Ozcelikay AT
    Int J Biol Macromol; 2016 Jan; 82():453-63. PubMed ID: 26455402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proniosomes: a novel drug carrier preparation.
    Hu C; Rhodes DG
    Int J Pharm; 2000 Sep; 206(1-2):110-22. PubMed ID: 11202988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proniosomes: a novel drug carrier preparation.
    Hu C; Rhodes DG
    Int J Pharm; 1999 Aug; 185(1):23-35. PubMed ID: 10425362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single Intravenous Dose of Novel Flurbiprofen-Loaded Proniosome Formulations Provides Prolonged Systemic Exposure and Anti-inflammatory Effect.
    Verma P; Prajapati SK; Yadav R; Senyschyn D; Shea PR; Trevaskis NL
    Mol Pharm; 2016 Nov; 13(11):3688-3699. PubMed ID: 27632682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentials of proniosomes for improving the oral bioavailability of poorly water-soluble drugs.
    Song S; Tian B; Chen F; Zhang W; Pan Y; Zhang Q; Yang X; Pan W
    Drug Dev Ind Pharm; 2015 Jan; 41(1):51-62. PubMed ID: 24111828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sucrose stearate-based proniosome-derived niosomes for the nebulisable delivery of cromolyn sodium.
    Abd-Elbary A; El-laithy HM; Tadros MI
    Int J Pharm; 2008 Jun; 357(1-2):189-98. PubMed ID: 18339494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol proniosomes as a convenient nanoingredient for functional food.
    Schlich M; Lai F; Pireddu R; Pini E; Ailuno G; Fadda AM; Valenti D; Sinico C
    Food Chem; 2020 Apr; 310():125950. PubMed ID: 31830712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of Aceclofenac Proniosomes by Using Different Carriers, Part 1: Development and Characterization.
    Sammour RMF; Taher M; Chatterjee B; Shahiwala A; Mahmood S
    Pharmaceutics; 2019 Jul; 11(7):. PubMed ID: 31323799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and characterization of catechin-loaded proniosomes for food fortification.
    Shruthi PA; Pushpadass HA; Magdaline Eljeeva Emerald F; Surendra Nath B; Laxmana Naik N
    J Sci Food Agric; 2021 Apr; 101(6):2439-2448. PubMed ID: 33027542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review on novel vesicular drug delivery: proniosomes.
    Yasam VR; Jakki SL; Natarajan J; Kuppusamy G
    Drug Deliv; 2014 Jun; 21(4):243-9. PubMed ID: 24128089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Review on Proniosomes: A Propitious Outlook to the Provesicular Drug Delivery System.
    Saxena A; Apurvi P; Aslam R
    Curr Drug Deliv; 2023; 20(8):1115-1126. PubMed ID: 36278459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proniosomal powder of captopril: formulation and evaluation.
    Gupta A; Prajapati SK; Singh M; Balamurugan M
    Mol Pharm; 2007; 4(4):596-9. PubMed ID: 17472398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proniosomes as a drug carrier for transdermal delivery of ketorolac.
    Alsarra IA; Bosela AA; Ahmed SM; Mahrous GM
    Eur J Pharm Biopharm; 2005 Apr; 59(3):485-90. PubMed ID: 15760729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A facile approach to manufacturing non-ionic surfactant nanodipsersions using proniosome technology and high-pressure homogenization.
    Najlah M; Hidayat K; Omer HK; Mwesigwa E; Ahmed W; AlObaidy KG; Phoenix DA; Elhissi A
    J Liposome Res; 2015 Mar; 25(1):32-7. PubMed ID: 24963602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technology overview and drug delivery application of proniosome.
    Ahmad MZ; Mohammed AA; Mokhtar Ibrahim M
    Pharm Dev Technol; 2017 May; 22(3):302-311. PubMed ID: 26794727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro skin permeation of estradiol from various proniosome formulations.
    Fang JY; Yu SY; Wu PC; Huang YB; Tsai YH
    Int J Pharm; 2001 Mar; 215(1-2):91-9. PubMed ID: 11250095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Different Carriers on In Vitro and In Vivo Drug Release Behavior of Aceclofenac Proniosomes.
    Sammour RMF; Chatterjee B; Taher M; Saleh MSM; Shahiwala A
    Curr Drug Deliv; 2021; 18(9):1272-1279. PubMed ID: 33605859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proniosomes: the effective and efficient drug-carrier system.
    Mittal S; Chaudhary A; Chaudhary A; Kumar A
    Ther Deliv; 2020 Feb; 11(2):125-137. PubMed ID: 31937205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.